Tonix Pharma (TNXP) Tops Q3 EPS by 270c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts TNXP Hot Sheet
Join SI Premium – FREE
Tonix Pharma (NASDAQ: TNXP) reported Q3 EPS of ($0.23), $2.70 better than the analyst estimate of ($2.93). Revenue for the quarter came in at $2.82 million versus the consensus estimate of $3.08 million.
For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloom Energy shares fall despite beating Q3 estimates
- Associated Banc-Corp (ASB) Tops Q3 EPS by 4c
- Orchid Island Capital (ORC) Misses Q3 EPS by 119c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
